EpiTET Therapeutics
Biotechnology Research
New Haven, Connecticut, United States
4 employees
- Employees
- 4
EpiTET Therapeutics Overview
- Headquarters
- New Haven, Connecticut, United States
- Industry
- Biotechnology Research
- Employees
- 4
- Founded
- 2024
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About EpiTET Therapeutics
EpiTET's novel targets and molecular glue degrader approach has the potential to revolutionize the way we treat a number of chronic inflammatory conditions including endometriosis, metabolic dysfunction (MASH), cancers, and other conditions. Our approach selectively eliminates pathogenic macrophages, the key drivers of chronic inflammation and disease micro-environment without suppressing overall immunity.
EpiTET Therapeutics Contact Details
- People in AeroLeads
- 3
EpiTET Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Helen Zhang | Student at Yale University | Singapore |
View
|
| Sophie Nguyen | Yale’28 Mcdb - Questbridge Scholar - Apia Scholar - 2023 Mit National Semifinalist - 2024 Isef Semifinalist | New Haven, Connecticut, United States |
View
|
| Rishit Shaquib | Student at Yale University, Majoring in Molecular, Cellular, and Developmental Biology, Pre-med |
View
|
Employees by Management Level
Individual contributor
3 profiles
Compare Similar Companies to EpiTET Therapeutics
Arvinas
Biotechnology Research
Canaan
Venture Capital And Private Equity Principals
Foresite Capital
Venture Capital And Private Equity Principals
BrightEdge - American Cancer Society
Venture Capital And Private Equity Principals
PsyMed Ventures
Venture Capital And Private Equity Principals
Nephrogen
Biotechnology Research
Cloverleaf Bio
Biotechnology Research
Partnology
Venture Capital And Private Equity Principals
Hybridex Biosciences
Biotechnology Research
ReNetX Bio
Biotechnology